Dr. Solomon I. Hamburg, MD

Dr. Hamburg practices at Excel Surgical Center, LLC in Beverly Hills, California.

Dr. Hamburg's NPI, 1801892302, was assigned on June 21, 2005. Dr. Hamburg graduated from New York University School of Medicine in 1981. Dr. Hamburg holds California license G53431.

Dr. Hamburg's primary practice is Excel Surgical Center, LLC, at 120 S Spalding Dr, Beverly Hills, CA 90212 in Los Angeles County. The practice phone is (818) 321-6865.

Dr. Hamburg's primary practice is Excel Surgical Center, LLC in Beverly Hills, California. Dr. Hamburg is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Hamburg to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamburg practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hamburg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hamburg is board certified in hematology by the American Board of Internal Medicine. Dr. Hamburg is licensed in California.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Hamburg treats.

CMS data shows 50,009 Medicare services from Dr. Hamburg across 36 procedure codes in 2024, for 556 Medicare patients. Medicare paid $427,479 for them.

CMS counts 556 Medicare patients who saw Dr. Hamburg in 2024. The largest group is 75 to 84, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hamburg's median patient age at 68, with 58% women.

In 2024, Dr. Hamburg wrote 941 Medicare Part D claims for 163 patients. 75% of them were for generic drugs. CMS names the drug for 575 of them, across 30 drugs with 11 or more claims each, at $2,231,991 in total drug cost. In 2023, CMS named 560 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Hamburg for performance year 2024, reported as part of a group. Dr. Hamburg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hamburg as offering telehealth.

Dmand AI links 20 papers to Dr. Hamburg, published from 2006 to 2021. 2018 was the busiest year, with 2. The most frequent topics are Macrophages, Phagocytosis and Interferon Inducers. Dr. Hamburg's most frequent co-authors are Lawrence B. Afrin, MD, Roger M. Lyons, MD and Josef T. Prchal, MD.

Dmand AI links Dr. Hamburg to 15 clinical trials, 12 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Adenocarcinoma, Bronchiolo-Alveolar, Squamous Cell Carcinoma of Head and Neck and Adenocarcinoma of Lung. National Cancer Institute (NCI) sponsors the most, 11.

CMS Open Payments shows 255 general payments to Dr. Hamburg from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Incyte Corporation paid the most, $217,147.

Dmand AI lists 4 awards for Dr. Hamburg, most recently Checkbook Top Doc in 2013.

Dr. Hamburg graduated from New York University School of Medicine in 1981. Dr. Hamburg is a member of ASCO and ASH.

Dr. Hamburg is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.